Hikal announces development of Favipiravir APIs and its intermediates
The company is in discussion with potential partners to supply the API and its intermediates
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COVID-19
Clariant in India extends support to local communities against COVID-19
The company reported that it has also contributed over Rs 32 lakhs to various government relief funds
Modi’s ‘self-reliance’ call need of the hour: Pharma industry
During these unprecedented times, the pharmaceutical industry has worked with the government in an integrated manner and continued…
Maharashtra FDA requests NPPA to fix prices of N-95 mask, PPE kits
2 ply masks, 3 ply masks and hand sanitisers are under price control since March 21, 2020
Health groups ask India to rescind Gilead’s patents for COVID-19 drug remdesivir
Gilead’s three patents in India for remdesivir stem from 2009 when the drug was in development to treat Ebola
Coronavirus vaccine possible in about a year, says EU agency
"For vaccines, since the development has to start from scratch ... we might look from an optimistic side in a year from now, so…
Merck registers an increase of 16.7 per cent in net sales
The COVID-19 crisis, which has meanwhile become a pandemic, only had a moderate impact in the first quarter of 2020, the company…
NovaLead Pharma to conduct Phase 3 trial for its repurposed anti COVID-19 drug
In a comparable viral assay study conducted by reputed laboratories in South Korea and United States, the drug, NLP21 has shown…
CDSCO examines export feasibility of hand sanitisers
Asks States /UTs to assess production, market availability of hand sanitisers
Russia claims Favipiravir shows promise against coronavirus in early trials
Favipiravir is also undergoing trials in India by Glenmark Pharmaceuticals